LeMaitre Vascular Inc

LMAT04 Dec 2024
Healthcare
$105.28
0.00 (-0.43%)
Lowest Today
$102.71
Highest Today
$105.33
Today’s Open
$105.28
Prev. Close
$105.47
52 Week High
$109.58
52 Week Low
$52.3
To Invest in LeMaitre Vascular Inc

LeMaitre Vascular Inc

Healthcare
LMAT04 Dec 2024
0.00 (-0.43%)
1M
3M
6M
1Y
5Y
Low
$102.71
Day’s Range
High
$105.32
102.71
52 Week Low
$52.3
52-Week Range
52 Week High
$109.58
52.3
1 Day
-
1 Week
-1.02%
1 month return
+8.71%
3 month return
+18.4%
6 month return
+35.52%
1 Year return
+92.63%
3 Years return
+114.7%
5 Years return
+190.44%
10 Years return
-
Institutional Holdings
BlackRock Inc
15.46
Conestoga Capital Advisors, LLC
8.8
Vanguard Group Inc
7.02
Conestoga Small Cap Investors
6.32
iShares Core S&P Small-Cap ETF
5.88
Copeland Capital Management, LLC
5.17
Geneva Capital Management
3.9

Market Status

Fundamentals
Market Cap
2371.39 mln
PB Ratio
7.27
PE Ratio
58.92
Enterprise Value
2300 mln
Total Assets
346.78 mln
Volume

Company Financials

Fund house & investment objective

Company Information
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Organisation
LeMaitre Vascular Inc
Employees
614
Industry
Medical Instruments & Supplies
CEO
Mr. George W. LeMaitre
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities